![FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients](https://mma.prnewswire.com/media/1714128/Xarelo_Liquid_Suspension_Contents.jpg)
FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
![China Customized XARELTO 2.5mg 10mg 15mg 20mg Rivaroxaban Tablets Reference Listed Drug Suppliers, Manufacturers - Factory Direct Price - TOSUN China Customized XARELTO 2.5mg 10mg 15mg 20mg Rivaroxaban Tablets Reference Listed Drug Suppliers, Manufacturers - Factory Direct Price - TOSUN](https://www.chinadrugservices.com/uploads/202331145/xarelto-2-5mg-10mg-15mg-20mg-rivaroxaban444477af-8794-4d9a-af3a-dcad77f648ac.png)
China Customized XARELTO 2.5mg 10mg 15mg 20mg Rivaroxaban Tablets Reference Listed Drug Suppliers, Manufacturers - Factory Direct Price - TOSUN
![These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=xarelto-37.jpg&id=748026)
These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for
![Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients - Interventional News Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients - Interventional News](https://interventionalnews.com/wp-content/uploads/sites/13/2019/08/2.5mg-Packaging-Green.png)
Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients - Interventional News
![FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients](https://mma.prnewswire.com/media/1714129/Xarelto_US_Pediatric_Tablet_Oral_Suspension.jpg?p=facebook)